Ningyun Sun

Title: Innovations of Ningyun Sun in Metabolic Disease Treatment

Introduction

Ningyun Sun is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of metabolic disease treatment through his innovative research and development. His work focuses on strains that can prevent and treat various metabolic diseases, showcasing his dedication to improving health outcomes.

Latest Patents

Ningyun Sun holds a patent for a strain designed for preventing and treating metabolic diseases. This strain, named SSYD-3, has the accession number CGMCC No. 14764. It is noted for its superior fermentation performance, storage stability, acid and bile resistance, and effectiveness in treating metabolic diseases compared to the existing strain ATCC BAA835. This innovation represents a significant advancement in the field of metabolic health.

Career Highlights

Throughout his career, Ningyun Sun has worked with notable organizations, including Sph Sine Pharmaceutical Laboratories Co., Ltd and the Shanghai Institute of Endocrine and Metabolic Diseases. His experience in these institutions has allowed him to develop and refine his innovative approaches to metabolic disease treatment.

Collaborations

Ningyun Sun has collaborated with esteemed colleagues, including Bin Wen and Guang Ning. These partnerships have contributed to the advancement of his research and the successful development of his patented strain.

Conclusion

Ningyun Sun's contributions to the field of metabolic disease treatment through his innovative strain SSYD-3 highlight his commitment to advancing healthcare solutions. His work continues to inspire future research and development in this critical area of medicine.